Treatment for resectable cervical esophageal carcinoma: A surgical perspective
- VernacularTitle:从外科视角看可切除颈段食管癌的治疗
- Author:
Zhen WANG
1
,
2
;
Jianjun QIN
1
,
2
;
Yong LI
1
,
2
;
Xiankai CHEN
1
,
2
;
Yin LI
1
,
2
Author Information
1. Department of Thoracic Surgery, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences &
2. Peking Union Medical College, Beijing, 100021, P.R.China
- Publication Type:Journal Article
- Keywords:
Cervical esophageal carcinoma;
surgery;
treatment;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(10):1217-1222
- CountryChina
- Language:Chinese
-
Abstract:
Definitive chemoradiotherapy (dCRT) is the general recommendation for the treatment of cervical esophageal cancer for organ preservation. However, the long-term survival of dCRT is not satisfactory. Surgical resection alone is not superior to dCRT in the treatment of cervical esophageal cancer. Surgical resection is often combined with laryngectomy, which will affect the quality of life. Recent evidence suggests that neoadjuvant therapy combined with surgery improves the long-term survival of cervical esophageal cancer. On the other hand, the development of technologies such as laryngeal preservation surgery and minimally invasive esophagectomy has reduced the risk of operation and improved the quality of life. This article will review the new progress in the comprehensive treatment of cervical esophageal cancer from the perspective of surgery.
